Bdron 500mg Tablet contains Abiraterone Acetate, a hormonal therapy used in the treatment of advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC).
| Composition | Abiraterone Acetate |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 60 Tablets |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Bdrelin 3.75mg Injection contains Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist used to treat hormone-sensitive conditions such as advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.
| Composition | Triptorelin |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 1 Vial |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Bdfoie 10 mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of certain types of cancers including thyroid cancer, advanced renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 10 Capsules |
| Prescribed For | Thyroid, Kidney, Lung Cancer |
| Expiry | December 2027 |
